Pfizer says its Covid vaccine is STILL 100% effective in children ages 12 to 15 four months after the second dose

Pfizer-BioNTech released data on Monday from a long-term analysis of their COVID-19 vaccine in kids aged 12 to 15. There were 30 confirmed symptomatic Covid cases in the placebo group compared to none in the vaccinated group Researchers say this equates to 100% efficacy at least four months after receiving the second dose. The vaccine is currently only fully approved for those aged 16 and older but the companies plan to apply for extended approval in the 12-15 age group soon